Disseminated Penicillium Marneffei infection with verrucoid lesions in an AIDS patient in Beijing, a non-endemic region.
Penicillium marneffei (PM) infection is prevalent in South-East Asia and Southern China and has been considered an acquired immunodeficiency syndrome (AIDS)-defining disease. This report focused on the verrucoid proliferative lesions of P. marneffei infection in a 34-year-old Chinese female AIDS patient from a non-endemic region. She recovered after receiving intravenous amphotericin B followed by oral itraconazole therapy. At the same time, highly active antiretroviral therapy (HAART) was also started. She responded very well to the treatment.
Li
HouMin
H
Department of Dermatology, Peking University People's Hospital, Beijing, 100044, China.
Sang
JuHua
J
Li
RuoYu
R
Liu
YanChun
Y
Zhang
JianZhong
J
D017088:AIDS-Related Opportunistic Infections / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D000328:Adult; D000666:Amphotericin B / Q000627:therapeutic use*; D044966:Anti-Retroviral Agents / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use*; D001706:Biopsy; D002681:China; D003881:Dermatomycoses / Q000188:drug therapy / Q000382:microbiology*; D003937:Diagnosis, Differential; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D017964:Itraconazole / Q000627:therapeutic use*; D010407:Penicillium / Q000302:isolation & purification*; D012867:Skin / Q000382:microbiology / Q000473:pathology*
D044966:Anti-Retroviral Agents; D000935:Antifungal Agents; D017964:Itraconazole; D000666:Amphotericin B